Suppr超能文献

非咪唑类组胺H3配体。第三部分。新型4-正丙基哌嗪作为非咪唑类组胺H3拮抗剂。

Non-imidazole histamine H3 ligands. Part III. New 4-n-propylpiperazines as non-imidazole histamine H3-antagonists.

作者信息

Walczyński Krzysztof, Zuiderveld Obbe P, Timmerman Henk

机构信息

Department of Synthesis and Technology of Drugs, Medical University Muszyńskiego, Muszyńskiego Street 1, 90-145 Łódź, Poland.

出版信息

Eur J Med Chem. 2005 Jan;40(1):15-23. doi: 10.1016/j.ejmech.2004.09.010.

Abstract

In search for a new lead of non-imidazole histamine H3-receptor antagonists, a series of 1[(2-thiazolopyridine)-4-n-propyl]piperazines, the analogous 1-[(2-oxazolopyridine)-4-npropyl]piperazines, 1-[(2-benzothiazole)-4-n-propyl]piperazine and 1-[(2-benzooxazole)4-n-propyl]piperazine were prepared and in vitro tested as H3-receptor antagonists (the electrically evoked contraction of the guinea-pig jejunum). It appeared that by comparison of homologous pairs the thiazolo derivatives have slightly higher activity than their oxazolo analogues. The most potent compound of these series is the 1-(2-thiazolo[4,5-c]pyridine)-4-n-propylpiperazine (3c) with pA2 = 7.25 (its oxazole analogue (4g) showed pA2 = 6.9). The structure-activity relationships for compounds with various positions of the nitrogen in the benzene ring for the thiazoles compared with oxazoles are discussed.

摘要

为寻找新型非咪唑类组胺H3受体拮抗剂,合成了一系列1-[(2-噻唑并吡啶)-4-正丙基]哌嗪、类似的1-[(2-恶唑并吡啶)-4-正丙基]哌嗪、1-[(2-苯并噻唑)-4-正丙基]哌嗪和1-[(2-苯并恶唑)-4-正丙基]哌嗪,并作为H3受体拮抗剂进行了体外测试(豚鼠空肠的电诱发收缩)。结果表明,通过同源物对的比较,噻唑衍生物的活性略高于其恶唑类似物。该系列中最有效的化合物是1-(2-噻唑并[4,5-c]吡啶)-4-正丙基哌嗪(3c),其pA2 = 7.25(其恶唑类似物(4g)的pA2 = 6.9)。讨论了噻唑与恶唑相比,苯环中氮处于不同位置的化合物的构效关系。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验